quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:16·115d
SECFiling
AEON Biopharma Inc. logo

SEC Form DEF 14A filed by AEON Biopharma Inc.

AEON· AEON Biopharma Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • AEON
    AEON Biopharma Inc.
    Health Care

Recent analyst ratings

  • Aug 18UpdateH.C. Wainwright$18.00

Related

  • INSIDER20d
    SEC Form 4 filed by Bencich John
  • INSIDER20d
    SEC Form 3 filed by new insider Bencich John
  • PR20d
    AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
  • SEC20d
    AEON Biopharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
  • PR20d
    AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
  • SEC24d
    SEC Form 10-K filed by AEON Biopharma Inc.
  • SEC24d
    AEON Biopharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR24d
    AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022